AHRQ Tech Assessment Supports Primary Prevention Implantable Defibrillators
This article was originally published in The Gray Sheet
Executive Summary
The agency affirms the evidence in favor of implantable defibrillators for primary prevention of sudden cardiac death is strong for patients with reduced left-ventricular ejection fraction, but does not support resynchronization ICDs for this population.